SMCHD1 and facioscapulohumeral muscular dystrophy 2: Mutations in the gene are linked to two distinct clinical phenotypes: the digenic dominant facioscapulohumeral muscular dystrophy type 2 (FSHD2) and the dominant Bosma arhinia microphthalmia syndrome (BAMS).